HOME >> MEDICINE >> NEWS
Artificial liver moves toward commercialization

Emergency device could save lives

SAN FRANCISCO -- In cases of severe liver failure, often the only effective alternative to keep a patient alive is a liver transplant. Due to a severe shortage of donor organs, many patients die waiting for suitable organs. An artificial liver that provides temporary support of a person's liver function can serve as a bridge to transplant or as a short-term treatment. Prototype devices, which filter blood toxins that build up as a result of liver damage, have been used in limited clinical trials to support patients. Advances in the development of this device, which could save many lives in the future, will be highlighted at the 219th national meeting of the American Chemical Society, the world's largest scientific society.

  • Upgraded device awaits human trials: The University of Minnesota bioartificial liver is among the earliest prototype devices still under development. To make it function longer than other models, researchers are using freshly isolated pig liver cells -- believed to work better than frozen liver cells -- as the substitute chemical-processing unit for the patient's liver. The first human clinical trials of this prototype device are scheduled to begin soon, pending U. S. Food and Drug Administration approval, among several patients with severe liver failure. (D. N. Adams, University of Minnesota, Minneapolis, Minn.; BIOT 81; Monday, March 27, 4:25 p.m.; Moscone Convention Center, Room 300, Esplanade Level. See page 68 in the final program.)

  • Improving device performance: Artificial livers currently being tested employ straight-line hollow fiber bioreactors to house the chemical-processing cells that substitute for the human liver. Such devices are subject to clogging and transport difficulties, resulting in poor transport of nu
    '"/>


Contact: charmayne Marsh
y_marsh@acs.org
202-872-4445
American Chemical Society
26-Mar-2000


Page: 1 2

Related medicine news :

1. Artificial liver trials show progress, as transplant candidates wait
2. Artificial organs
3. New Type Of Artificial Surfactant Shows Promise In Treating Lung Disease
4. Trial Begins For First Artificial Liver Device Using Human Cells
5. Research offers hope of new treatments for liver damage
6. Success of liver transplantation may be most influenced by three risk factors
7. Alcohol relapse adversely affects 10-year liver transplant survival
8. Donor age has no affect on long-term liver transplant survival
9. NHS stop-smoking services are insufficient to deliver national smoking targets
10. New ways to design safer & more effective topical (transdermal) drug delivery announced in the PNAS
11. Component of green tea protects injured livers in mice

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/20/2017)... ... , ... Clearwave is the leading provider in ... XT-series of touch screen terminals. Both companies will be showcasing their solutions at ... provider Posiflex is helping to bridge the gap between healthcare hardware and software ...
(Date:2/20/2017)... ... 20, 2017 , ... Best Doctors® and IBM today announced ... companies that want to help members of their workforce battling cancer. Through the ... Watson’s suite of oncology offerings for insights on cancer treatment options, ranging from ...
(Date:2/20/2017)... TX (PRWEB) , ... February 20, 2017 , ... Chuck ... of Sensory Sensitive Sundays, a joint event at Chuck E. Cheese’s locations throughout New ... and other special needs, the opportunity to experience the fun of visiting Chuck E. ...
(Date:2/19/2017)... ... 19, 2017 , ... Braun Industries will be participating as an exhibitor at ... take place February 23-25, 2017 at the Calvin L. Rampton Salt Palace Convention Center ... new ambulances on display. , “JEMS is a leader in EMS ...
(Date:2/18/2017)... ... February 17, 2017 , ... ... Sponsored by Axendia, **FDAnews Free Webinar**, March 1, 2017 — 1:30 p.m. ... reduce their regulatory burden? Pay dividends in enhanced and predictable product performance? ...
Breaking Medicine News(10 mins):
(Date:2/20/2017)... Feb. 20, 2017 Research and Markets has ... Insights, Opportunity, Analysis, Market Shares & Forecast 2017 - 2022" ... ... nearly USD 2 Billion by the year end of 2022 growing ... Market growth can be attributed to factors such as ...
(Date:2/20/2017)... , Feb. 20, 2017   AT&T ... physicians diagnose and treat patients with cardiovascular disease ... wireless connectivity for ZywiePro, Zywie,s cardiac remote monitoring ... Control Center . AT&T and Zywie ... for those with the disease. The Internet of ...
(Date:2/20/2017)... 2017 Seal Shield LLC ( Jacksonville, ... mobile device management and disinfection, the ElectroClave™, to the ... in Orlando, Fla. from February ... have become commonplace in today,s healthcare landscape, but with ... concerns, including the disinfection and tracking of these devices.  ...
Breaking Medicine Technology:
Cached News: